White & Case advised pharmaceutical multinational Takeda in connection with two distinct operations. The first matter sees Takeda involved as the seller of a pharmaceutical products portfolio, currently licensed to Hikma Pharmaceuticals. The buyer
White & Case advised pharmaceutical multinational Takeda in connection with two distinct operations. The first matter sees Takeda involved as the seller of a pharmaceutical products portfolio, currently licensed to Hikma Pharmaceuticals. The buyer